Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on refinancing transaction relating to the INEOS group
Mandate

Vinge advises on refinancing transaction relating to the INEOS group

February 17, 2010

Vinge has advised a bank syndicate including Barclays Capital, Bank of America Merrill Lynch and ING Bank in connection with the Swedish part of the refinancing of the INEOS group (the world's third largest chemicals company) and the group company, Kerling PLC's bond issue for EUR 785 million. Kerling PLC is one of Europe's leading producers of PVC and caustic soda.
 
The INEOS group refinancing has secured assets in five jurisdictions, including Sweden.
 
Vinge's team primarily consisted of Fredrik Wilkens (responsible partner), Emma Stuart-Beck, Katarina Rodell and Karin Lidman.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025